Myocardial Perfusion Imaging: Clinical Experience and Recent Progress in Radionuclide Scintigraphy and Magnetic Resonance Imaging

Overview

Journal Int J Card Imaging

Specialties Cardiology & Vascular Diseases
Radiology

Date 1997 Nov 14

PMID 9360178

Citations 1

Authors

J T Keijer

J J Bax

A C van Rossum

F C Visser

C A Visser

Affiliations

Soon will be listed here.

Abstract

In the past 20 years, radionuclide scintigraphy has proven to be a sensitive clinical tool in the assessment of myocardial perfusion abnormalities. Magnetic resonance imaging may also be used to study myocardial perfusion, but its potential value still has to emerge in the clinical setting. This review addresses the potential and achievements of both methods in clinical cardiology.

Citing Articles

Measurement of kinetic parameters in skeletal muscle by magnetic resonance imaging with an intravascular agent.

Faranesh A, Kraitchman D, McVeigh E Magn Reson Med. 2006; 55(5):1114-23.

PMID: 16598733 PMC: 2041870. DOI: 10.1002/mrm.20884.

References

Detrano R, Janosi A, Lyons K, Marcondes G, Abbassi N, Froelicher V . Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram. Am J Med. 1988; 84(4):699-710. DOI: 10.1016/0002-9343(88)90107-6. View

Nishimura T, Kobayashi H, Ohara Y, Yamada N, Haze K, Takamiya M . Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. AJR Am J Roentgenol. 1989; 153(4):715-20. DOI: 10.2214/ajr.153.4.715. View

Kaul S, Kelly P, Oliner J, Glasheen W, Keller M, WATSON D . Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiography. J Am Coll Cardiol. 1989; 13(2):468-82. DOI: 10.1016/0735-1097(89)90528-7. View

Zaret B, Rigo P, Wackers F, Hendel R, Braat S, Iskandrian A . Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Circulation. 1995; 91(2):313-9. DOI: 10.1161/01.cir.91.2.313. View

Fintel D, Links J, Brinker J, Frank T, Parker M, Becker L . Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis. J Am Coll Cardiol. 1989; 13(3):600-12. DOI: 10.1016/0735-1097(89)90600-1. View

Eichstaedt H, Felix R, Dougherty F, Langer M, Rutsch W, SCHMUTZLER H . Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA. Clin Cardiol. 1986; 9(11):527-35. DOI: 10.1002/clc.4960091102. View

van Rossum A, Visser F, van Eenige M, Sprenger M, Valk J, Verheugt F . Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Am J Cardiol. 1990; 65(13):845-51. DOI: 10.1016/0002-9149(90)91425-6. View

Leppo J, Meerdink D . Comparative myocardial extraction of two technetium-labeled BATO derivatives (SQ30217, SQ32014) and thallium. J Nucl Med. 1990; 31(1):67-74. View

Keijer J, van Rossum A, van Eenige M, Bax J, Visser F, Teule J . Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: quantitative comparison with (201)Thallium-SPECT and coronary angiography. J Magn Reson Imaging. 2000; 11(6):607-15. DOI: 10.1002/1522-2586(200006)11:6<607::aid-jmri6>3.0.co;2-7. View

10.

Sinusas A, Shi Q, Saltzberg M, Vitols P, Jain D, Wackers F . Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med. 1994; 35(4):664-71. View

11.

Mahmarian J, Verani M . Exercise thallium-201 perfusion scintigraphy in the assessment of coronary artery disease. Am J Cardiol. 1991; 67(14):2D-11D. DOI: 10.1016/s0002-9149(05)80002-5. View

12.

Schmitt-Willich H, Frenzel T, Press W, Weinmann H . In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging. Invest Radiol. 1991; 26(11):969-74. DOI: 10.1097/00004424-199111000-00008. View

13.

Berman D, Kiat H, Van Train K, Garcia E, Friedman J, Maddahi J . Technetium 99m sestamibi in the assessment of chronic coronary artery disease. Semin Nucl Med. 1991; 21(3):190-212. DOI: 10.1016/s0001-2998(05)80040-6. View

14.

Pflugfelder P, Wisenberg G, Prato F, Turner K, CARROLL S . Serial imaging of canine myocardial infarction by in vivo nuclear magnetic resonance. J Am Coll Cardiol. 1986; 7(4):843-9. DOI: 10.1016/s0735-1097(86)80346-1. View

15.

Higgins C, Saeed M, Wendland M . Contrast enhancement for the myocardium. Magn Reson Med. 1991; 22(2):347-53; discussion 364-5. DOI: 10.1002/mrm.1910220239. View

16.

DePuey E, Rozanski A . Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med. 1995; 36(6):952-5. View

17.

Hoffman J . Transmural myocardial perfusion. Prog Cardiovasc Dis. 1987; 29(6):429-64. DOI: 10.1016/0033-0620(87)90016-8. View

18.

Porter T, DSa A, Turner C, Jones L, Minisi A, Mohanty P . Myocardial contrast echocardiography for the assessment of coronary blood flow reserve: validation in humans. J Am Coll Cardiol. 1993; 21(2):349-55. DOI: 10.1016/0735-1097(93)90674-p. View

19.

Eigler N, Schuhlen H, Whiting J, Pfaff J, Zeiher A, Gu S . Digital angiographic impulse response analysis of regional myocardial perfusion. Estimation of coronary flow, flow reserve, and distribution volume by compartmental transit time measurement in a canine model. Circ Res. 1991; 68(3):870-80. DOI: 10.1161/01.res.68.3.870. View

20.

Muhler A . Assessment of myocardial perfusion using contrast-enhanced MR imaging: current status and future developments. MAGMA. 1995; 3(1):21-33. DOI: 10.1007/BF02426397. View